ConductScience.org, home

Trial · NCT02586155

Results by group192

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Incidence of First Occurrence of Adjudication-confirmed Narrowly Defined MACEHigh-Intensity Statin Therapy+RVX000222CV Death34events
Incidence of First Occurrence of Adjudication-confirmed Narrowly Defined MACEHigh-Intensity Statin Therapy+PlaceboCV Death42events
Incidence of First Occurrence of Adjudication-confirmed Narrowly Defined MACEHigh-Intensity Statin Therapy+RVX000222Non-fatal MI76events
Incidence of First Occurrence of Adjudication-confirmed Narrowly Defined MACEHigh-Intensity Statin Therapy+PlaceboNon-fatal MI92events
Incidence of First Occurrence of Adjudication-confirmed Narrowly Defined MACEHigh-Intensity Statin Therapy+RVX000222Stroke15events
Incidence of First Occurrence of Adjudication-confirmed Narrowly Defined MACEHigh-Intensity Statin Therapy+PlaceboStroke15events
Incidence of First Occurrence of Adjudication-confirmed Broadly Defined MACEHigh-Intensity Statin Therapy+RVX000222CV Death33events
Incidence of First Occurrence of Adjudication-confirmed Broadly Defined MACEHigh-Intensity Statin Therapy+PlaceboCV Death42events
Incidence of First Occurrence of Adjudication-confirmed Broadly Defined MACEHigh-Intensity Statin Therapy+RVX000222Non-fatal MI74events
Incidence of First Occurrence of Adjudication-confirmed Broadly Defined MACEHigh-Intensity Statin Therapy+PlaceboNon-fatal MI91events
Incidence of First Occurrence of Adjudication-confirmed Broadly Defined MACEHigh-Intensity Statin Therapy+RVX000222Hospitalization for CVD events22events
Incidence of First Occurrence of Adjudication-confirmed Broadly Defined MACEHigh-Intensity Statin Therapy+PlaceboHospitalization for CVD events18events
Incidence of First Occurrence of Adjudication-confirmed Broadly Defined MACEHigh-Intensity Statin Therapy+RVX000222Stroke15events
Incidence of First Occurrence of Adjudication-confirmed Broadly Defined MACEHigh-Intensity Statin Therapy+PlaceboStroke15events
Incidence of Hospitalization for Congestive Heart Failure (CHF)High-Intensity Statin Therapy+RVX00022229events
Incidence of Hospitalization for Congestive Heart Failure (CHF)High-Intensity Statin Therapy+Placebo48events
Incidence of All-cause MortalityHigh-Intensity Statin Therapy+RVX00022261Participants
Incidence of All-cause MortalityHigh-Intensity Statin Therapy+Placebo72Participants
Change in Apolipoprotein A1 (ApoA-I) Concentration From Baseline Over Time Within and Between Treatment GroupsHigh-Intensity Statin Therapy+RVX000222Baseline119.0Inter-Quartile Range 110.0 to 130.0mg/dL
Change in Apolipoprotein A1 (ApoA-I) Concentration From Baseline Over Time Within and Between Treatment GroupsHigh-Intensity Statin Therapy+PlaceboBaseline117.5Inter-Quartile Range 108.0 to 128.0mg/dL

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02586155/results